China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Financial Reports
Annual Report  2019 2018
Annual Report
 
More  
Monthly Newsflash
2019 Sep Newsflash 2019
Sep Newsflash
 
More  
Financial Calendar
 
Reverse Roadshow
5 June 2018
 
  More
  China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong Stock Exchange. Shineway is one of the Hang Seng Composite Index constituents and is named by Forbes Magazine as Asia's Best 200 Under a Billion.

Our products are primarily categorized into three major types: injection, soft capsule and granule, targeting three market segments with high growth potential, namely the middle and old aged, anti-viral and children, and are marketed under the "SHINEWAY" brand - a China Famous Trademark.
Latest News
Announcements and Notices - 2019 Interim Results Announcement   30 Aug 2019
Announcements and Notices - Notice of Board Meeting   20 Aug 2019
Announcements and Notices - List of Directors and Their Roles and Functions   02 Jul 2019
Product Highlight
 
Qingkailing Soft Capsules
Clearing away heat and toxins...
 
  More  
Related Links
Email Alerts
Industry Regulations
Shineway's China Website Related Website of Pharmaceutical Industry